TOMY Boon Highchair Recall Issued After Dozens of Falls, Infant Injuries

The manufacturer has received numerous reports of the highchairs separating from their bases, resulting in the chairs, and the children in them, falling over.

More than 85,000 TOMY highchairs have been recalled, following reports of problems where the seat suddenly separated from the pedestal base, resulting in at least two dozen incidents where children fell from the highchairs, often suffering injuries, bruises and scratches.

The U.S. Consumer Product Safety Commission (CPSC) announced the TOMY highchair recall on August 31, indicating that the bolts used to secure the seat to the pedestal base can become loose and allow the seat to detach. This can pose a fall hazard to the child occupant inside.

TOMY has received 34 reports of the chair separating from the base, which has resulted in reports of at least 24 falls and 11 child injuries.

The recall includes Boon Flair highchairs manufactured before September 2016 and all Boon Flair Elite highchairs manufactured at any time. The Flair Elite has a white and orange molded plastic seat with a white tray and metal pedestal base. Flair highchairs have a gray plastic pedestal base and were sold in 10 color combinations, including blue/white, white/orange, pink/white, green/white, gray/green, white, gray, white/gray, white/blue, and red/white. The recall includes model numbers B751, B701–B709, B716–B718, B731, B10147, B11068, B11069, and B11401.

Consumers can check the model number and manufacturing date code printed on the label located under the base of the highchair.

According to the recall notice, about 83,000 of the recalled highchairs were sold in the U.S., with another 2,850 sold in Canada. They were manufactured in China and distributed by TOMY, based in Oak Brook, Illinois.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The highchairs were sold at Bed Bath & Beyond, Target, Toys ‘R’ Us, and other stores nationwide, as well as online at Amazon.com, Target.com, Walmart.com, and BedBathAndBeyond.com.

Flair Elite highchairs were sold from 2008 to 2009 for about $380. The Flair models were sold from January 2008 through February 2017 for between $230 and $250.

The CPSC recommends consumers stop using the affected highchairs immediately and contact TOMY for a free repair kit. The repair kit will include a set of bolts and split and flat washers to repair the recalled highchair.

Consumers with questions about the recall should contact TOMY at 866-725-4407 or online at https://recall.tomy.com.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Lawsuit Alleges Suboxone Caused Dental Damage, Erosion and Tooth Decay
Lawsuit Alleges Suboxone Caused Dental Damage, Erosion and Tooth Decay (Posted today)

Kentucky man has filed a lawsuit against Suboxone manufacturers, indicating the opioid treatment film strips were known for years to cause the kind of permanent tooth damage he suffered, long before warning labels were added by the drug manufacturer.

Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL
Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL (Posted 3 days ago)

Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.

Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit
Six Years of Depo-Provera Injections Caused Woman To Develop Intracranial Meningioma: Lawsuit (Posted 4 days ago)

California woman indicates she was unaware there was a link between her meningioma and Depo-Provera injections until a study was published in March 2024, resulting in widespread publicity about the brain tumor risks.